european dna essay contest 2022

European essay competition success for Perse students

Sheen Gahlaut and Sneha Goni (both Lower Sixth) delved into DNA as they achieved success in an international biology essay competition.

The Perse students came first and second respectively in the European DNA Day Essay Contest , with both investigating the question ‘How can DNA help us to discover ancient history?’

For their efforts in the competition, organised by the European Society of Human Genetics, Sheen and Sneha received cash prizes, while The Perse was awarded €1,800 to be used for a biology project.

Sheen said: “I just wanted to look into something a bit different outside of school studies, so it’s pretty amazing to have won the competition,” while Sneha commented: “I’m really happy, especially as it’s a topic I didn’t know much about before.”

Both students are considering a career in medicine and were keen to look into a topic in which there is much ground-breaking research taking place.

Sheen said: “I take a mix of A levels – sciences and history – and I’ve always enjoyed doing projects where there’s a combination of subjects.

“I thought it would be interesting to explore how ancient and modern genomes can be used, so I also looked at how we combined them and how they influence each other.

“I started by looking at the more known-about elements, such as gene development and admixture of different species, but I was really interested in the cultural aspect of it and how social norms have been passed on through time.

“The difference between ancient and modern genomes was quite striking. It’s a topic I’d like to keep track of now I know a lot more about the basics behind it.”

Sneha said: “I started off looking at how we can show population migration and admixture, and also disease and the environment people were living in at the time.

“I think it has quite a nice link to how researchers are now talking about whole genome sequencing in medicine and to help determine diseases.”

Published 11 July 2022

Designed by Svelte Design | Built by Highrise Digital

• Privacy Overview
• Strictly Necessary Cookies
• 3rd Party Cookies

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website. It helps our team to understand which sections of the website you find most interesting and useful.

You can read our privacy overview here .

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Wellington College

• An Introduction to Wellington
• The Master’s Mission
• Our Purpose, Vision & Attitude
• Our Heritage
• The Wellington Community
• Our Family of Schools
• Inspections
• Leaders & Governors
• Admissions Overview
• Our Selection Criteria
• Joining at 11+
• Joining at 13+
• Joining at 14+
• Joining at 16+
• Visiting Wellington
• Virtual Tour
• Scholarships
• College Fees
• Assistance with Fees
• International Pupils
• Our Learning Philosophy
• Academic Faculties
• Beyond the Classroom
• Fireside Talks
• Examination Results
• Academic Support
• Progress & Reporting
• Universities & Careers
• Digital Learning
• Global Citizenship
• Expeditions & Adventure
• Excellence in Care
• Safeguarding
• Healthy Eating
• Health Centre
• Our House System
• Minibus Service
• The College Shop
• Life Beyond Wellington
• Wellington College Learning Alliance
• Festival of Education
• Grants & Donations
• Easter Revision Course
• Conferences
• Sustainability
• What’s New
• Latest News
• The Master’s Voice
• College Calendar
• Sport Fixtures
• Sport Results
• College Term Dates
• Publications
• Get in Touch
• How to Visit Us
• Where We Are
• Department Contacts
• The Master’s Voice
• Wellington College International
• Parents’ Hub

DNA Day Essay contest 2022

15 July 2022

Latest news

Congratulations to Alicia R T, Charlie G, Anouschka H and Mei Mei W on becoming winners of The European DNA Day Essay contest 2022.

The essay contest is meant as a learning tool and a means to promote knowledge of genetics within Europe. It intends to challenge students to examine, question and reflect on the importance and social implications of genetic research and its applications. Essays are expected to contain substantive, well-reasoned arguments indicative of a depth of understanding of the issues addressed by the selected essay question.

Students from 22 European countries submitted 167 essays and 23 videos this year. The evaluation was made involving 62 experts in the field, who selected 3 winners and 7 honourable mentions.

Alicia achieved third place   and Charlie, Anouschka and Mei Mei received honourable mentions. 

Click HERE to read the winning submissions.

Share article:

Related news

Caitlin and Liesl Wellington’s Triathlon Champions Head to Istanbul!

Arthur Shines in First Season with British Athletics Paralympic Futures, Eyes 2028 Paralympics

Cressida’s Cambridge Commendation

Prev article

Next article

News & Events

Log in to the ASHG Portal to submit or view your submission. 

Welcome to the 2022 DNA Day Essay Contest submission site!

Submission deadline is March 2, 2022 at 11:59 pm U.S. Eastern Time

Submission Instructions

• If you HAVE submitted an essay since 2019, please use these instructions
• If you HAVE NOT  submitted an essay in after 2019, please use these instructions
• Review a blank submission form   to prepare your submission

What You Need to Know Before You Submit

• Teachers should create an account and submit the essay for each student. This can be any teacher at the current school of the student.
• The contest is open to high school students (grades 9-12) in the U.S. and internationally
• Essays must be in English and no more than 750 words. Word count includes in-text citations, but not reference lists.
• Essays must include at least one reference. 

SUBMIT ESSAY HERE

For more information about the ASHG DNA Day Essay Contest, visit the contest homepage . 

Questions? Contact us at [email protected]

• Presentación
• Junta directiva
• Comisiones y Delegados
• Para Pacientes
• Noticias AEGH
• Actividades
• Bolsa de trabajo
• Congresos AEGH
• Cursos AEGH
• Jornadas AEGH
• Cursos organizados AEGH

European DNA Day Essay Contest

Dear Genetics Colleagues,

The DNA Day essay contest had a great year in 2014. We had almost 170 essays submitted from 20 countries. This number has grown from about 90 the first year. The “top three” participating countries were Italy, Cyprus and Poland. Some countries participated for the first time, such as Spain and Albania. These 170 essays represent some 140 science classrooms.

For the 8 th year, the European Society of Human Genetics (ESHG) will be sponsoring a DNA Day Essay contest in European high schools as part of International DNA Day activities.

The winners will again be announced on April 25, DNA Day . This should foster the participation of more students/classes, by giving science teachers time to plan this into their curricula for the year. This schedule will allow winning classes to enjoy their prizes and give teachers the opportunity to use the winning essays as a teaching tool.

This year’s themes to be chosen from are:

• Do you think genome sequencing will impact on your future life? Give examples of what you would want and what you would not want to happen because of genome sequencing.
• How can you explain human complexity when we have so few protein coding genes, e.g. about 5,000 less than a cucumber?

Please use the essay contest as means to promote knowledge of genetics in your country and within Europe. The ESHG would also be pleased to learn about other DNA Day activities that you may be hosting in your country; you are welcome to submit these at [email protected] .

On a practical basis, we suggest that you:

o Use existing contacts and “educational partners” from your country to disseminate information on the contest to schools, teachers, principals

o Send a letter to secondary schools in your country, referring them to the DNA Day website ( www.dnaday.eu ), which will have information on this year’s questions/contest directives early in November. Your national genetics society or other organization may also choose to create a website in your county, or provide a link to the ESHG‘s DNA Day site.

o Promote the DNA Day essay contest and other DNA Day activities through radio, television, newspapers and social networking.

We invite you to take a look at the DNA Day website for previous questions, essays, memorable quotes and information on participating countries from contests in previous years: www.dnaday.eu . The contest is open to students ages 15-19, who should submit their essays electronically between November 15 and March 15. Winning essays will be announced via the ESHG website on April 25 as well as at the annual European Society meeting in Glasgow, Scotland, UK in June. The top three essays will be awarded monetary prizes, one for the student and a second for the class/teacher. All students who submit an essay will receive a certification of participation.

Please let us know how the ESHG can help you promote DNA Day!

Yours sincerely,

Información relacionada

Deja un comentario Cancelar respuesta

Tu dirección de correo electrónico no será publicada.

Save my name, email, and website in this browser for the next time I comment.

Publicar comentario

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios .

• Resumen de privacidad
• Cookies estrictamente necesarias

Esta web utiliza cookies para que podamos ofrecerte la mejor experiencia de usuario posible. La información de las cookies se almacena en tu navegador y realiza funciones tales como reconocerte cuando vuelves a nuestra web o ayudar a nuestro equipo a comprender qué secciones de la web encuentras más interesantes y útiles.

Las cookies estrictamente necesarias tiene que activarse siempre para que podamos guardar tus preferencias de ajustes de cookies.

Si desactivas esta cookie no podremos guardar tus preferencias. Esto significa que cada vez que visites esta web tendrás que activar o desactivar las cookies de nuevo.

• Architettura e Design
• Arte e Cultura
• Scienza e innovazione
• #coronavirus
• I prossimi eventi
• Segnala un evento
• Prenota uno spazio
• Tutti gli articoli
• Comunicati stampa

European DNA Day essay and video contest: annunciati i vincitori dell'edizione 2022

15th annual european dna day essay and video contest for high school students: chi ha vinto.

Studentesse e studenti degli ultimi due anni delle scuole secondarie di II grado di 22 Paesi europei hanno partecipato all'edizione 2022 del concorso che ogni anno, da quindici anni, viene bandito in occasione del  DNA Day :   il 25 aprile si ricorda la data ufficiale di pubblicazione del lavoro scientifico con il quale James Watson , Francis Crick , Maurice Wilkins , Rosalind Franklin presentarono per la prima volta la struttura del DNA.

Il tema proposto " How can DNA help us to discover ancient human history? ” è stato sviluppato in  167 elaborati scritti e 23 video . Dieci scuole superiori liguri, con studenti e studentesse affiancati dai propri docenti di Scienze, hanno partecipato alle attività seminariali organizzate dalla Genetica Medica del Dipartimento di neuroscienze, riabilitazione, oftalmologia, genetica e scienze materno-infantili - DINOGMI dell'Università di Genova per promuovere e supportare gli studenti nella partecipazione al concorso .

La Società Europea di Genetica Umana ( European Society of Human Genetics, ESHG ) ha annunciato i nomi dei vincitori del concorso durante la sessione di chiusura dei lavori del congresso annuale della società ( ESHG conference 2022 ) tenutosi a Vienna nel mese di giugno.

Con grande piacere l'Università di Genova, impegnata anche in questa occasione nella formazione e nel supporto ai più giovani, condivide il risultato ottenuto dalle due studentesse  Aurora Piccardo e Stella Panavija , classe 4B del Liceo Classico D’Oria di Genova, che hanno ricevuto il terzo premio del video contest . Ad Aurora e Stella le più vive congratulazioni per essersi cimentate in questa esperienza e per l’ottimo risultato raggiunto. Un ringraziamento alla Prof.ssa Anna Barberis , docente di classe delle due studentesse vincitrici, e a tutti gli studenti e le studentesse che si sono preparati al contest partecipando ai seminari proposti da UniGe .

Sul sito DNA Day Contest è pubblicato l'elenco dei vincitori con gli elaborati presentati.

Articoli simili

Leggere la Cina di oggi: incontri con gli autori

Legislative drafting and the rule of Law. Constitutional challenges and opportunities for Ukraine on the EU accession process

SHARPER 2024: appuntamento venerdì 27 settembre con la Notte europea dei ricercatori e delle ricercatrici

Nella stessa categoria.

Sequenziato, pubblicato e analizzato il genoma del vertebrato più longevo: lo squalo della Groenlandia

Intelligenze artificiali autodidatte?

AAA cercasi Ambassador per promuovere i corsi gratuiti RAISE

Scopri il Potere della Narrazione nelle Terapie Espressive a Genova!

Formarsi alla cittadinanza digitale: i corsi gratuiti RAISE

• Università di Genova
• universitàdigenova
• mensilmente
• sostenibilità
• coronavirus
• dipartimentodilingue
• intelligenza artificiale

UniGe©2019-2023 - Università di Genova Via Balbi 5, 16126 Genova - Partita IVA: 00754150100 Testata giornalistica online UniGe Life Reg. n°09/2021 al Tribunale di Genova in data 03/08/2021 [email protected]

• Training camps
• Introduction
• Textbook list
• Study group
• Science fair and research coaching
• International Biology Olympiad
• About Brain Bee
• Participating countries
• Brain Bee news
• Brain Bee resources
• Success stories
• Science opportunities
• Mock olympiads
• Australian Science Olympiad Competition
• Indian Biology Olympiad (INBO)
• Science Bowl
• South African National Biology Olympiad
• Toronto Biology Competition
• Study notes
• Tips and Tricks
• Developing practical skills
• Solving problems
• Textbook notes
• Crash course

Category Archive

Below you'll find a list of all posts that have been categorized as “Competitions”

New 21-Week Training Camp: Accommodating UK and Asian Timezones for Biology Olympiad Preparation

martyna p September 20, 2024 Competitions

We are excited to announce the launch of our 21-week intensive training camp, designed to prepare students for the UK, Hong Kong, and Singapore Biology Olympiad exams! This program is tailored to accommodate both UK and Asian timezones, making it accessible for students across the globe. Our training camp is structured to equip you with the knowledge and problem-solving skills …

🌟 Join Our British Biology Competitions Training Camp! 🌟

martyna p September 6, 2024 Competitions

Dear Parents and Students,Are you passionate about biology and ready to take your knowledge to the next level? I’m excited to announce that I am launching a British Biology Competitions Training Camp designed to help students excel in this prestigious competition!🔬 What You’ll Gain: In-depth preparation for the Biology Challenge, Intermediate Biology Olympiad and British Biology Olympiad (BBO) topics and …

How to Prepare for the Brain Bee: Insights from 2024 USA Brain Bee Champion Harini Venkatesh

martyna p September 4, 2024 Brain Bee news , Competitions

We are thrilled to share an inspiring story from one of our star students at Biolympiads Academy, Harini Venkatesh, who recently triumphed at the 2024 USA National Brain Bee Championship. Harini’s journey to success is a testament to her dedication, hard work, and the power of comprehensive preparation—qualities that we emphasize in our programs at Biolympiads Academy. Harini Venkatesh: A …

USABO 2025: A Comprehensive Guide to the USA Biology Olympiad

martyna p September 3, 2024 Competitions

The USA Biology Olympiad (USABO) is one of the most prestigious academic competitions for high school students in the United States, offering a unique platform for budding biologists to showcase their knowledge and skills. As we approach the 2025 competition season, it’s essential for students, educators, and parents to stay informed about the latest updates, deadlines, and requirements. Here’s a …

A Closer Look at the 2024 Hong Kong Biology Olympiad

The 2024 International Biology Olympiad – Hong Kong Contest (IBO-HKC) is fast approaching, offering a golden opportunity for Hong Kong’s brightest young biologists to showcase their skills and compete on an international level. Here’s everything you need to know about this prestigious event and how to get involved. Key Details of the Contest Date: November 10, 2024 (Sunday) Time: 11:30 a.m. to …

Unlocking the Future: How Biolympiads Can Help Your Child Excel in the USA Biology Olympiad (USABO)

In today’s competitive academic landscape, finding opportunities that truly challenge and inspire students is essential for unlocking their full potential. For students with a passion for biology, few experiences are as rewarding—and as challenging—as participating in the USA Biology Olympiad (USABO). As the premier biology competition for high school students in the United States, the USABO is a gateway to …

Unlocking the Connection: How AP Biology Prepares Students for the USA Biology Olympiad (USABO)

martyna p September 2, 2024 Competitions

For students passionate about biology, few academic challenges are as rewarding as the Advanced Placement (AP) Biology course and the USA Biology Olympiad (USABO). These two milestones represent rigorous opportunities to deepen one’s understanding of biological concepts and to demonstrate excellence in the subject. However, what many students and parents may not realize is how closely related AP Biology and …

Join Our Introductory Neuroscience Training Program – Prepare for the Brain Bee!

martyna p September 1, 2024 Brain Bee news , Competitions

Are you passionate about the human brain? Ready to take your interest in neuroscience to the next level? We’re excited to invite you to join our Introductory Neuroscience Training Program, a specialized 9-week course designed to prepare highly motivated students for the Brain Bee competition. About the Program: The Brain Bee is an international neuroscience competition that challenges high school students …

USMDO 2024 results announced

martyna p August 17, 2024 Competitions

We are excited to share the list of the top medal winners of the 2024 US Medicine and Disease Olympiad (USMDO)! Congratulations to all who participated—your hard work and dedication to the field of medicine and biology are truly commendable. 2024 USMDO Results Total Scored Competitors: 996 Mean Score: 71.37 Standard Deviation: 35.15 For those eagerly awaiting further results, please …

Register for the 2025 USABO!

martyna p July 28, 2024 Competitions

As a new school year begins, it’s the perfect time to start planning for the 2025 USA Biology Olympiad (USABO). This prestigious competition offers students an incredible opportunity to showcase their knowledge and passion for biology on a national stage. Important Dates and Details: Registration Opening Date: Mark your calendar for the first day to register for the 2025 USABO, …

Introductory Neuroscience Summer Camp 2024

martyna p June 28, 2024 Competitions

​🚀 Dive into the World of Neuroscience! 🧠 🧩 Are you fascinated by the mysteries of the brain? 💡 Ever wondered how we think, feel, and remember? Join our Neuroscience Course and unlock the secrets of the human mind! Designed for school students, this exciting program will take you on a journey through the incredible landscape of the brain. 🌟 Highlights: Interactive Lessons: Engage with fun, hands-on activities. Cool …

MCR Biology contest

martyna p May 31, 2024 Competitions

Hello everyone, Medicine Community & Research, a 501c3 student led non-profit organization, is excited to announce the MCR Biology contest sponsored by Biolympiads! This contest is designed for elementary and middle school students passionate about biology! Elementary and Middle School students will participate in different divisions of the competition to ensure fairness. The contest questions will focus on eukaryotic cell …

Biolympiads student Harini Venkatesh Triumphs at 2024 USA Brain Bee Championship

martyna p May 27, 2024 Competitions

The 2024 USA National Brain Bee Championship, held April 19-21 at the University of Central Florida, featured 54 top students from 32 states. Harini Venkatesh, a 10th grader from New Hampshire, won first place, earning $1,500 and a chance to compete in the International Brain Bee. She is a student of the Biolympiads Academy. Second and third places went to …

🌟 Calling All Innovative Students! 🌟

martyna p May 25, 2024 Competitions

🌟 Calling All Innovative Students! 🌟 Do you have a groundbreaking idea that could change the world? Are you ready to showcase your entrepreneurial spirit and compete for amazing prizes? Join the Pitch for the Future competition today and take your chance to shine! 🚀 What’s in it for you? Incredible Prizes: Win cash prizes, mentorship opportunities, and more! Networking: Connect with …

Triumph at the USABO 2024: Two Biolympiads Students Make it to the Top 20 National Camp

martyna p May 23, 2024 Competitions

In a remarkable display of academic excellence and dedication, two exceptional students from Biolympiads community have achieved the prestigious honor of being selected for the Top 20 National Camp in the 2024 USA Biology Olympiad (USABO). This accomplishment underscores their hard work, intellectual prowess, and the quality of education provided by their schools. The USA Biology Olympiad, a rigorous and …

US Medicine and Disease Olympiad 2024

martyna p May 11, 2024 Competitions

US Medicine and Disease Olympiad The USMDO, the US Medicine and Disease Olympiad, is America’s qualifying competition for the IMDO, the International Medicine and Disease Olympiad. The first USMDO was held in 2022 and qualified 8 students for the 2022 IMDO, almost all of whom won gold medals at the international competition. The third annual USMDO will take place on Saturday, 8/11/2024. …

BIORESEARCH ACADEMY SUMMER CAMP 2024

martyna p May 8, 2024 Competitions

Since the inaugural program in 2017, BioResearch Academy’s mission has been to enlighten young, motivated biological scientists on thinking creatively about research problems. It aims to inspire the next generation of researchers through transformative instruction and social learning within an intimate community of like-minded peers. CURRICULUM Developed by Harvard Professor Samuel Kunes and Martyna Petrulyte, the curriculum combines preparation for …

2024 Rachel Carson Intergenerational Sense of Wonder/Sense of the Wild Contest

martyna p April 3, 2024 Competitions

In her honor, the Rachel Carson Landmark Alliance holds an annual Intergenerational “Sense of Wonder, Sense of the Wild” contest, inviting teams with members of two or more generations to write poems and essays about nature. Contest entries with this theme involve an intergenerational team (2 or more individuals from different generations) undergoing positive, outdoor, nature-centered experiences. Team members then …

Maurice R. Hilleman Essay Contest 

The Maurice R. Hilleman Essay Contest is a program of the Vaccine Makers Project (VMP), presented by the Vaccine Education Center at Children’s Hospital of Philadelphia (VEC). The VMP provides free school-based materials about the immune system, diseases, vaccines, STEM careers, and evaluating information. Who? Students in grades 6 to 12* living in the United States (including District of Columbia …

ESHG DNA Day Essay & Video Contest

martyna p April 2, 2024 Competitions

What is the DNA DAY Contest? The structure of the DNA double helix was unraveled seventy years ago. DNA Day, April 25, is commemorated internationally as a celebration of Genetics and its promises. For the 15th year, the European Society of Human Genetics (ESHG), will be sponsoring a DNA Day Essay and Video contest in high schools all over the …

• Page 1 of 6

The European Society of Human Genetics

Survey on need for registration of bioinformaticians as clinical laboratory geneticists (focus on bioinformatics).

In case, you are interested in registration as European registered Clinical Laboratory Geneticists (focus on Bioinformatics) under the conditions mentioned below, send a mail to [email protected]‐jena.de until 31.03.2025 just stating that you would like to use that way to show your competence.

More information

Report on ESHG Course: 8th Workshop on the History of Human Genetics

This course explored the history of eugenics, tracing its origins to Francis Galton and its connection with Berlin's Kaiser-Wilhelm-Institute. The symposium focused on the period before and after 1945, examining global eugenics and the often overlooked contributions of female scientists in human genetics. Their challenges in gaining recognition were highlighted, alongside ethical questions integrated into the discussion.

ESHG DNA Day Essay & Video Contest 2024: The winners are announced

Over 240 submissions in total were received from 29 countries this year and scored in a blinded review by a panel of ESHG members. More information on this year's winners can be found on the DNA Day website www.dnaday.eu

Alexander Gusev wins the 2024 Leena Peltonen Prize

The winner of this year’s Leena Peltonen prize, to be awarded at the ESHG annual meeting being held in Berlin, Germany, is Alexander (Sasha) Gusev, Associate Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School.. The prize is awarded to an outstanding young researcher in the field of human genetics, and honours the memory of Dr Leena Peltonen, a world-renowned human geneticist from Finland who died in 2010 and who contributed greatly to the identification of disease genes for human diseases.

Sasha Gusev’s postdoctoral training was at the Harvard School of Public Health and his PhD in Computational Biology and Computer science at Columbia University. His lab at Dana-Farber focuses on the genetic architecture of cancer and disease risk:  characterising the mechanisms of cancer risk and how common regulatory variation leads to cancer, understanding how germline variation shapes the tumour and cancer evolution once cancer develops, and integrating genetic variation and electronic health records data to improve clinical decision-making and treatment outcomes.

His work includes development of the widely-used Transcriptome-Wide Association Study (TWAS) approach to identify potential susceptibility genes from Genome-Wide Association Studies. More recently, his group has expanded TWAS methods to incorporate large-scale allele-specific and epigenetic measurements.

His group has led pharmacogenetic studies that identified one of the first germline variants associated with immunotherapy toxicities, and developed novel machine learning approaches for the classification of cancers of unknown primary. His broader goal is to leverage genetic variation to identify novel disease prevention opportunities and match optimal treatments for the right patients.

Download the latest issue of the ESHG Newsletter

This issue contains the annual reports of the ESHG committee chairs, the European Journal of Human Genetics and the EBMG. Enjoy reading also the interviews of the ESHG Award speakers Cecilian Lindgren, ESHG Awardee , James Lupski, Mendel Lecturer , and Angus Clarke, EMPAG Awardee 2024 .

Download the newsletter now.

Download the ESHG 2024 Conference App

The ESHG Society App for smartphones and tablets is now available for iOS and Android and contains the full programme of the ESHG 2024 conference. All conference data and additional society information are available. Search for ‘ESHG’ or ‘European Soc. of Human Genetics’ in the stores or click the links on this page .

With our deepest sorrow, we inform you that Virginia Nunes passed away

Virginia Nunes, a pioneer in human genetics in Spain, Head of IDIBELL and Professor at the University of Barcelona, passed away on May 24, 2024.

Opting-in to data sharing in the European Health Data Space will disadvantage research on personalised medicine, says ESHG

The European Society of Human Genetics is deeply concerned by the European Parliament’s decision to mandate an opt-in provision for the sharing of human genetic, genomic, and proteomic data in the proposed European Health Data Space, believing that it could substantially hinder progress in the field of human genetics within Europe.

Rare diseases diagnostics should be exempt from the Vitro Diagnostic Medical Devices Regulation

We express our concerns on the impact of certain provisions on our community and urge the European Commission to take action.

Call for research project proposals 2024 edition

The Mia Neri Foundation Onlus (MNF) will fund two basic research projects on childhood brain tumors with a €100,000 grant. Submission until June 30th.

ESHG reacts to adoption of opt-in system for the use of genomic data in the EHDS

European Parliamentarians have approved the proposal for an opt-in system for the use of genetic data.

Opt-in Regulation Proposal for the European Health Data Space

ESHG President Valérie Cormier Daire expresses concerns on a provision in Article 33 of the Regulation proposal for the European Health Data Space in a letter to the members of the EU Committee on the Environment, Public Health and Food Safety.

PEC Member Yves Moreau receives the Einstein Foundation Award 2023

The ESHG wishes to congratulate PEC member Yves Moreau, professor of engineering science at the Katholieke Universiteit Leuven, for winning this prestigious award. The Jury of the Einstein Foundation Award said "Yves Moreau forcefully advocates for ethical standards in the utilization of human DNA data in research and privacy-preserving analysis of clinical genetic data in the age of artificial intelligence and big data.”.

Congratulations on behalf of the ESHG and its members!

Prof. Michael Speicher – 1960-2023

Professor Michael Speicher, who has died unexpectedly at 63, was a great friend to ESHG as well as being an outstanding scientist.  He had been head of the Diagnostic and Research Institute of Human Genetics at the Medical University of Graz since 2006, and since 2018 deputy head of the Diagnostic and Research Centre for Molecular Biomedicine.

He was president of the Austrian Society of Human Genetics from 2012 to 2018, and vice-president since then. As a former member of the ESHG Scientific Programme Committee, he worked with many of the Society’s officers and committee members. Former Chair of the SPC Professor Joris Veltman said: “Michael pioneered the use of genetics approaches to study the human genome from multiple angles. He developed the use of karyotyping human chromosomes by combinatorial multi-colour fluorescence in situ hybridization (FISH) in the 90s. He also used FISH to make the first three-dimensional maps of all chromosomes in human nuclei and identify chromosomal territories. On top of this, he successfully used genomic and transcriptomic approaches to identify cancer-predisposing mutations and pioneered the use of liquid biopsies to identify circulating tumour cells and cell-free DNA.”

He will be missed by all who knew him as an open-minded person who never allowed his scientific success and reputation to change his fundamentally modest and generous character.

Svante Pääbo speaks to The Guardian

Svante Pääbo, Nobel Laureate and ESHG Award Lecturer 2015 talks to Kate Conolly of the Guardian.

Click here to read the full article.

ESHG Endorses IVDR statements in "Call to Action" from the Expert Conference on Rare Diseases

The ESHG Executive Board has officially endorsed the Call to Action from the Expert Conference on Rare Diseases – Towards a new European policy framework on rare diseases : “Building the future together for rare diseases”, October 25 and 26, 2022 in Prague, with special focus on the IVDR-related statements of the document.

The ESHG has addressed a formal letter to the responsible person at the Czech Ministry of Health, the check Republic presiding the Council of the European Union in the second half of 2022, specifically highlighting the importance of lowering the performance study requirements for 'orphan diagnostics' at the beginning of test implementation (when clinically required) without having to lose quality assurance.

• Download Call to Action
• Technical meeting under the auspices of the Presidency of the Czech Republic in the Council of the EU . Brno, Czech Republic, July 23, 2022.
• Download Report: Towards a New European Policy Framework: Building the future together for rare diseases
• Eurordis Press Release: "21 Member States endorse Czech EU Presidency’s Call to Action on rare diseases at EPSCO Council Meeting"

Happy 30th Birthday, EJHG!

It is 30 years since the first issue of the  European Journal of Human genetics  was published. To celebrate this, the EJHG publishes a series of comments on significant papers published in the journal in the past 30 years and present an online web collection of papers selected by our editorial board.

Access the online web collection here: www.nature.com/articles/s41431-022-01188-6

ESHG picks another winner! Svante Pääbo, 2015 ESHG Award Lecturer, gets the Nobel Prize

Swedish geneticist Professor Svante Pääbo has won the 2022 Nobel Prize in Physiology or Medicine for discoveries that underpin our understanding of how modern day humans evolved from extinct ancestors. Pääbo, director at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, won the prize for "discoveries concerning the genomes of extinct hominins and human evolution," the Award committee said. “His discoveries provide the basis for exploring what makes us uniquely human.”

Born in Stockholm, Svante Pääbo studied medicine and biochemistry at Uppsala University before creating the scientific discipline paleogenomics, which has shed light on the genetic differences that distinguish living humans from extinct hominins. His ancient forensics work also has implications for modern medicine, for example by showing why some people are at higher risk of severe COVID. In 2020 he and colleagues published a paper showing that a genetic variant inherited by modern humans from Neanderthals when they interbred made those who carried it more likely to require artificial ventilation if infected.

His Nobel comes two years after another ESHG prizewinner, Professor Emmanuelle Charpentier, shared the 2020 Chemistry award with Professor Jennifer Doudna for the invention of the gene-editing technology CRISPR/Cas9. Prof Charpentier gave the ESHG Mendel Lecture at the Society’s annual conference in 2018.

ESHG President, Professor Borut Peterlin, said: “Svante has not only made a huge contribution to human genetics, but also opened up an entirely new field. I am sure that all our members join with me in sending him hearty congratulations.”

An interview with Svante Pääbo can be found here: secure.eshg.org/interviews2015.0.html His award lecture of 2015 can be found here: client.cntv.at/eshg2015/PL5

Jean-Jacques Cassiman - 1943-2022

Over decades, Jean-Jacques Cassiman was linked inseparably to the destiny of the European Society of Human Genetics, which he accompanied through its rebirth by facilitating the incorporation of ESHG in Belgium in 1991.

"JJ" had the role of ESHG Secretary General (1991-1997), ESHG President (2008-2009), and became first awardee of the EHSG Honorary Award in 2014. He also co-founded the International Federation of Human Genetics Societies in 1996.

Jean-Jacques passed away peacefully and serenely in the presence of his family on Friday, August 5. He will be sorely missed by all who knew and advanced together with him.

ESHG IVDR Webinar - Talks are still available

The session recordings of the ESHG Webinar on the IVD EU regulation (IDVR 2017/746) on June 22 are now available for on demand streaming.

Access the session recordings

Genetic Sounds - A Colourful Chat about all Things Genetic

Listen to the sixth and final episode of our genomics live podcast session talk from the European Human Genetics Conference 2022 in Vienna. In this episode, we discuss the wide topic of “What is the future in genetics?”

EPISODE 6 - WHAT IS THE FUTURE IN GENETICS? On the panel we have a wonderful range of guests including; Gijs WE Santen a clinical geneticist from the Netherlands with a special interest in dysmorphology, in particular Coffin-Siris syndrome, and prenatal genetic testing. Professor Clara Gaff , an Executive Director for Melbourne Genomics who has worked in public health, government, academic and not-for-profit sectors. Khadijah Bakur , a Genetic counsellor with expertise in understanding the role of religion -specially the role of Islam - on decision making for patients. And Alexander Hoischen , who has expertise in the identification of rare disease genes using latest genomics tools. Hosted by Nichola Garde and Mariangels Ferrer-Duch .

Now available on your favourite podcast player.

Select your player

EJHG Impact Factor rises to 5.31

The 2022 impact factor for the European Journal of Human genetics has risen to 5.31 (from 4.26), and is now ranked 35 out of 193 journals in "Genetics and Heredity".

"This reflects consistent hard work from our section editors, editorial board members and the staff of the EJHG office in Sheffield and at SpringerNature", says Alisdair McNeill, Editor in chief of the ESHG.

ESHG 2022 - Conference Press Releases

Find all press releases in the context of the ESHG 2022 conference here .

Andrea Ganna wins the 2022 Leena Peltonen Prize

The winner of this year’s Leena Peltonen prize, to be awarded at the ESHG annual meeting being held in Vienna, Austria, is Dr Andrea Ganna, from the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and Harvard Medical School. The prize is awarded to an outstanding young researcher in the field of human genetics, and honours the memory of Dr. Leena Peltonen, a world-renowned human geneticist from Finland who died in 2010 and who contributed greatly to the identification of disease genes for human diseases.

Andrea Ganna started as a FIMM-EMBL group leader at the Institute for Molecular Medicine Finland (FIMM), University of Helsinki in 2019. He did his post-doc at the Analytical and Translation Genetic Unit at Massachusetts General Hospital, Harvard Medical School and his PhD at Karolinska Institute. His research interests concern the intersection between epidemiology, genetics, and statistics, and to that end he started the FinRegistry project. FinRegistry uses nationwide registry data to build machine learning models to help better understand and predict the onset of diseases in the Finnish population.

He has authored and co-authored both methodological and applied papers focusing on leveraging large-scale epidemiological datasets to identify novel sociodemographic, metabolic, and genetic markers of common complex diseases. He currently leads two major international consortia: the COVID-19 host genetics initiative and the H2020 INTERVENE consortium. His research vision is to integrate genetic data and information from electronic health records/national health registries to enhance the early detection of common diseases and public health interventions.

ESHG features in the 2022 Kavli Prize for Neuroscience awards

Two researchers with strong ESHG connections are among the four winners of this year’s Kavli Prize for neuroscience. The Kavli Prize is given by the Norwegian Academy of Science and Letters in recognition of innovative scientific research.

Jean-Louis Mandel, ESHG President from 1999-2000, is recognised for his work on Fragile X syndrome, which has led to improved diagnostic tools and become a model for other neurological diseases. The unstable repeat expansions that he discovered n Fragile X are now known as the mechanism behind more than 50 genetic disorders.

Huda Zoghbi gave the Mendel Award Lecture at the 2013 ESHG annual conference. She is honoured for her discovery, jointly with Harry Orr, another Zavli prizewinner, of ATXN1, the gene whose mutations are responsible for spinocerebellar ataxia1. She also discovered the gene MECP2, whose abnormal levels cause Rett syndrome.

The fourth 2022 prize-winner, Christopher Walsh, is honoured for his discovery of more than three dozen genes implicated in neurological disease and how they affect the development of a child’s brain.

“Understanding inherited brain disorders has been made possible by the novel genetic approaches developed by this year’s laureates,” Kristine Walhovd, chair of the Kavli Prize Neuroscience Committee, said at the award ceremony in Oslo. “Together, these four scientists uncovered the genetic basis of multiple brain disorders and in doing so, paved the way to the development of diagnostic tools and improved care for those affected.”

ESHG Statement on the Situation in Ukraine

Dear ESHG Members, Dear colleagues, dear friends,

We wish to join other scientific societies in expressing our full support and great sympathy for the Ukrainian people, ESHG members and fellow scientists.

We greatly deplore the loss of life and destruction resulting from the invasion of Ukraine.

The ESHG being a society dedicated to academia, science, and education, we feel it is essential to support our Ukrainian colleagues and their patients at this difficult time. The ESHG has therefore decided to grant free access to Ukrainian scientists wishing to attend our conference in June, either virtually or in person. Additionally, Ukrainian presenters of posters and talks have been granted travel fellowships. The ESHG will also create a fund to facilitate the re-establishment of human genetics services in Ukraine as soon as the situation allows it.

Should it be possible for you to employ Ukrainian genetic specialists who are able to leave the country, please consider doing so. All support is appreciated, and special dispensations are in place in many countries.

On behalf of the genetic community, we would like to encourage our members and friends to donate to charities active on the ground.

Our hearts are with all Ukrainians at this time. We all hope for a rapid end to this war.

With best regards,

Maurizio Genuardi President of the ESHG, on behalf of the Executive Board

Survey on Expanded Carrier Screening - Your help is requested

Please take a couple of minutes to take a survey on expanded carrier screening developed in cooperation with the European Society of Human Reproduction and Embryology ESHRE.

Your help is appreciated, whether you offer ECS at your center or not. Your input will be a very important resource for our project.

The use of polygenic risk scores in pre-implantation genetic testing; an unproven, unethical practice, says ESHG

Despite there being no evidence that polygenic risk scores 1 (PRSs) can predict the likelihood of as-yet unborn children being liable to a specific disease in the future, some private fertility clinics have begun to sell PRS analyses on embryos to prospective parents.  This practice raises many concerns, says the European Society of Human Genetics in a paper published today (Friday 17 December) in the European Journal of Human Genetics *.

While it is quite normal for parents to consider any genetic risks they may pass to their children, this would usually be done by performing genetic testing for chromosome anomalies or single gene related conditions. In these cases, the ability of the test to predict the development of the disease in any offspring is high.

PRSs are a completely different matter. Many conditions are caused by a complex combination of genetics and environment, and PRSs are only able to capture parts of the relevant genetic component.  And when applied to selecting embryos for transfer in IVF, the PRS will relate to an individual family rather than to a wide population, and therefore will not be very useful in determining the choice of one embryo over another.

In addition, they have never undergone clinical trials to test their diagnostic effectiveness in embryos. Research on PRSs aims rather to contribute to the understanding of disease mechanisms and, perhaps more speculatively, to the management and treatment of liveborn, mostly adult, individuals. In fact, such trials in embryos would be wellnigh impossible, given that one might have to wait decades for the predicted disorder to appear (or not).

So, at present, performing a PRS test for embryo selection would be premature, at best. Adequate, unbiased information on the risks and limitations of this practice should be provided to prospective parents and the public. And it is vital that a societal debate takes place before any potential application of the technique in embryo selection.  Such a debate should be focused on what would be considered acceptable with regards to the selection of individual traits, in particular. Without proper public engagement and oversight, the practice of implementing PRS tests for embryo selection could easily lead to discrimination and the stigmatisation of certain conditions.

At a time when healthcare resources are under strain, it is important that the limited money available should be spent on tests that are known to be effective. Currently, research resources would be better spent on improving knowledge about how PRSs interact with the environment in which we live, rather on the premature application to our future children of an inadequately assessed test with potentially misleading results.

www.nature.com/articles/s41431-021-01000-x

1 A polygenic risk score reflects an individual’s estimated genetic predisposition to a given disorder and can be used in predicting the likelihood of that individual developing the disorder

New committee to oversee ethical issues relating to genomic research to be created

In the light of concerns about the many ethical issues posed by the handling and interpretation of DNA data from minorities, the ESHG intends to set up a (Gen)Ethics Oversight Committee (GEOC) to review and develop guidelines on ethical issues, particularly those related to population genetics. Although ESHG has no direct connection with DNA collection or the databases that are problematic in this respect, the committee will instigate a complaints procedure, as well as a route map for the handling of publications with a difficult ethical background in the Society’s journal, The European Journal of Human Genetics .

The GEOC will liaise with other ESHG committees over the development of a Society Code of Ethics, the improvement of publication practices, and the instigation of training courses on this topic. It will also investigate and make recommendations on individual cases.

“To date international scrutiny has focused mainly on unethical practices in population genetics on other continents,” said Dr Francesca Forzano, chair of the Society’s Public and Professional Policy Committee. “But there are also problems closer to home, and we need to make sure that these are dealt with effectively. DNA data used in population research must always be obtained and used in a strictly ethical way, following the rigorous standards highlighted in documents as the WMA Declaration of Helsinki. This means, for example, being certain that properly informed consent has been obtained. Sadly, we know that this has not always been the case in the past.

“Genetic research today holds out so much promise for the improvement of human health, and it is thus vital for the public good that trust should be maintained, and openness encouraged.”

New EU Research Project “Screen4Care” is now live!

Accelerating Diagnosis for Rare Disease Patients Through Genetic Newborn Screening and Artificial Intelligence

Serena Nik-Zainal wins Francis Crick Medal

ESHG Scientific Programme Committee member Dr Serena Nik-Zainal has been awarded the UK Royal Society’s Francis Crick Medal and Lecture 2022 for ‘enormous contributions to understanding the aetiology of cancers by her analyses of mutation signatures in cancer genomes, which is now being applied to cancer therapy’. The award is made annually in any field in the biological sciences. Preference is given to genetics, molecular biology and neurobiology, the general areas in which Francis Crick worked, and to fundamental theoretical work, which was the hallmark of Crick’s science.

Professor Alexandre Reymond, vice-president of ESHG and chair of the Scientific Programme Committee (SPC) said: “I would like to congratulate Serena on a fantastic achievement.  The presentation of this award underlines the chance we have to have some exceptional and dedicated scientists in the SPC, which in turn translates into the excellent science presented at our annual conference.”

ESHG Virtual Conference 2021 welcomed over 4,000 delegates

The ESHG is happy to announce that more than 4,000 delegates from 84 countries participated in the second virtual European Human Genetics Conference from August 28-31, 2021.

The ESHG wishes to thank all scientific attendees and especially our industry partners for their continuous support through those challenging times.

Missed a presentation? No problem, all talks, posters and session "re-lives" are still available until November 1.

Missed the entire conference? Also no problem, you can still register at discounted fees to watch all presentations on demand until November 1.

Access the virtual platform here

Thierry Frébourg 1960-2021

Prof. Thierry Frébourg passed away on the 13th of March at the age of 60 years. An active member of ESHG, he has worked in the Scientific Program Committee and for several years as Section Editor of the European Journal of Human Genetics.

He was the founder of the clinical genetic services of Normandy and of a mixed University-Inserm research unit in Rouen. His clinical and scientific achievements and organization skills were appreciated nationwide, and he was assigned important roles in national scientific organizations.

One of his major scientific interests was in the TP53 related tumor predisposition syndrome. He had the goal to improve the treatment of patients affected with these tumors and cancer prevention in carriers at risk, and has closely collaborated with the French Li-Fraumeni Syndrome Association and with the European Reference Network on genetic tumour risk syndromes (GENTURIS). His last achievemnt in the field has been the publication of clinical guidelines, an essential step towards the standardization of care for subjects dealing with this rare condition.

The French and the European human genetics communities will greatly miss him, along with his enthusiasm for science and dedication to patients.

Coercive collection of DNA is unethical and damaging to the future of medical research

The compulsory collection of DNA being undertaken in some parts of the world is not just unethical, but risks affecting people’s willingness to donate biological samples and thus contribute to the advancement of medical knowledge and the development of new treatments, says a paper in the European Journal of Human Genetics , published online* today [18 January 2021].

Citing abuses being carried out in China, Thailand, and on the US/Mexico border, the authors 1 call on scientific journals to reexamine all published papers based on databases that do not meet accepted standards of ethical approval, and demand an end to collaborations between academic institutions worldwide and those in countries carrying out unethical DNA collections.  They also advocate that companies making equipment used in DNA analysis should stop sales to the institutions involved in ethically tainted genetic research.

While journals ask that studies submitted to them should have ethical approval, they may fail to recognise that some ethics committees do not abide by expected ethical standards. Citing the compulsory collection of DNA samples from ordinary people being carried out by the Chinese authorities in Xinjiang province as part of a programme of surveillance and control, the authors say: "It appears that almost half of over a thousand articles describing forensic genetics studies in Chinese populations have at least one co-author from the Chinese police, judiciary, or related institutions.  It is impossible to carry out forensic population genetics research in China independently from the Chinese authorities. All this literature is thus potentially ethically tainted."

The paper calls on publishers to conduct a mass reassessment of the literature and to require further information on consent and ethical approvals, in addition to considering whether the studies fulfill the basic ethical requirements for non-maleficence, beneficence, justice, and veracity. "Such an assessment would be important if, in the future, any doubt arises about the data and the uses to which they may be put."

Companies should reconsider their position too, says the paper. Thermo Fisher Scientific has decided to stop sales of equipment to Xinjiang police forces, but such action by one company alone is insufficient to tackle the problem. "The only effective way would seem to be to stop sales to police and judiciary forces across China of products used in the identification of humans by means of molecular genetics. Other Western suppliers, such as Promega and QIAGEN, should follow suit."

The example of Kuwait is encouraging, say the authors.  In 2015, the Kuwaiti government became the first in the world to introduce a law requiring the compulsory collection of DNA samples from all citizens, residents, and visitors to the country. Such a measure was introduced purportedly to discourage terrorism, but many suspected that it could lead to genetic discrimination against some vulnerable minorities. The following year, after an international campaign against the measure, the law was dropped.

"While China, the USA, and Thailand are very different countries from Kuwait, both in their size and their leadership, the Kuwaiti example gives us reason to hope that international pressure may have an effect. We are concerned that the growing public awareness of abusive DNA collections will have a detrimental effect on the image of genetics in the wider world," say the authors.   

"In this time of COVID-19, Chinese science is increasingly under scrutiny from all quarters. The country’s reaction to the pandemic has been widely praised. It is surely not in their interest to damage their standing in the scientific world by continuing with what are clearly unethical and discriminatory practices," they conclude.

* www.nature.com/articles/s41431-020-00786-6

1 Dr Francesca Forzano, Prof Maurizio Genuardi, Prof Yves Moreau, writing on behalf of the European Society of Human Genetics

mRNA vaccines do not change DNA

There has been considerable discussion of Covid-19 vaccination on social media, and some posts have led people to be concerned that the new messenger RNA (mRNA) vaccines will change their DNA. In an attempt to clarify the situation, the European Society of Human Genetics would like to reassure the public that there is no evidence to support such concerns and that, if there were, we would not hide it.  

mRNA vaccines do not change DNA. Rather, they introduce molecules that lead to the production of harmless small fragments of the virus into cells. This causes the cells to make a part of the virus protein that strongly activates the immune system to produce a response against it. In this way the body will respond quickly when it comes into contact with the real, whole virus.

Vaccination prevents serious forms of Covid-19, including its potential complications. Individual genetic makeup (DNA) remains unchanged. All that happens is that the production of antibodies and defensive white blood cells is stimulated, in exactly the same way as happens when someone gets a viral infection naturally. The mRNA in cells is broken down very quickly and cannot reproduce itself. Thus the mRNA fragment cannot merge or directly integrate with the individual’s own natural DNA.

Brexit threatens British participation in rare disease European Reference Networks

In a <link https: www.thelancet.com journals lancet article fulltext _blank external-link-new-window internal link in current>letter published in The Lancet , a group of British experts have warned that a no deal Brexit could result in the exclusion of the UK from the 24 European Reference Networks (ERNs) that work to improve the care of patients with rare diseases.  ERNs were set up because no one country has the expertise or resources to cover the thousands of rare diseases, and geneticists are particularly involved in the diagnosis and treatment of rare disease patients, and as such, with ERNs. « We would be saddened if, as a result of Brexit, the UK were to be excluded from ERNs in the future, and we believe this would be very harmful to British patients living with rare diseases. We hope sincerely that an acceptable solution may be found before the end of the year, when the change will come into effect, » said ESHG President-elect Professor Maurizio Genuardi.

GertJan B. van Ommen – September 28, 1947 – November 7, 2020

“GertJan was the heart of the EJHG. We will remember his enthusiasm, his argumentation, and all he did for the Society in general. We thank him.” said ESHG President Alexandre Reymond, opening the Board meeting that took place on Friday 13 November.

This sentiment will be echoed by all who knew and worked with GertJan, who was editor in chief of the European Journal of Human Genetics for the last 25 years, as well as being president of the ESHG in 2002-2003, and the ESHG Award Laureate in 2011. In the interview he gave for the latter, he summed up his approach to science – and to life. “I like to do repairs; to look at things, find out what’s broken, and then do something about it.”  

GertJan undertook his studies in Amsterdam, where he lived until his death.  He was head of the Human Genetics department at Leiden University Medical Centre from 1992 to 2012. His main scientific interest was in neurodegenerative and neuromuscular disorders such as Huntington’s disease and Duchenne muscular dystrophy. He made major contributions to the treatment of both, for example discovering a therapy that induced exon skipping in DMD. He was one of the first to see this potential use of exon skipping: “We can use it for interfering in biological processes like moving proteins around and blocking signals.   The interesting thing about antisense RNA relative to RNAi  is that you can tweak its activity more precisely, rather than just destroying it, and thereby regulate many different processes.”

He will be remembered for his scientific prowess, but it is perhaps his humanity and wit that will linger longest in the hearts of those who knew him. He was an inspiring mentor to many young scientists and enjoyed setting up collaborations. “So many people have complementary skills, but sometimes in national science policy they are too busy making people compete and forget how much more you can achieve jointly with a large group of people, especially in the science of today.   I enjoy trying to get these groups of people to work together.”

He admitted that he only half-seriously suggested that he might become editor of the EJHG following Giovanni Romeo (“I had been a pop music critic and then editor of a computer journal”), and said that he was honoured, but also scared, when offered the job. And what a job he made of it! The EJHG went from a bimonthly journal of a few hundred pages to a monthly with nearly 2000, and the impact factor rose steadily.

GertJan was tireless in the pursuit of excellence in every area of his life; a wonderful colleague and collaborator who will be missed by so many people. ESHG sends our deepest condolences to his family, of whom he spoke with so much affection.

ESHG 2018 Mendel Lecturer Emmanuelle Charpentier is joint winner of 2020 Nobel Prize for Chemistry

A European geneticist is one of the two winners of this year’s Nobel Prize for chemistry, the first time that two women have shared the prize. Emmanuelle Charpentier, from the Max Planck Unit for the Science of Pathogens, Berlin, Germany, and Jennifer A  Doudna, from the University of California, Berkeley, USA won the prize for the invention of CRISPR/Cas9, or "the development of a method for gene editing", according to the citation from the Nobel committee.

"Professor Charpentier gave a most exciting and interesting talk as the Society’s Mendel Lecturer in 2018. In the eight years since its discovery, CRISPR/Cas9 has made remarkable contributions to basic and applied research, and has taken life sciences into a new era," said ESHG President Professor Alexandre Reymond. "We send our heartiest congratulations to the winners."

You can read an interview with Professor Charpentier <link https: index.php speakers speaker-interviews emanuelle-charpentier _blank external-link-new-window internal link in current>here.

ESHG Policy Statement on Regulation EU 2017/746 (the IVD Regulation)

Regulation EU 2017/746 (the IVD Regulation) is a threat to both precision medicine and crisis management if the Article 5-§5 conditions (d)-(i) are not removed

Compulsory large-scale collection of DNA is unethical and should stop

The <link https: www.nytimes.com world asia china-dna-surveillance.html _blank external-link-new-window internal link in new>New York Times reported on 17 June 2020 that the Chinese government is collecting DNA from ordinary people as part of a programme of surveillance and control. This is in contradiction to existing regulations and safeguards concerning the collection of DNA samples from individuals. Collection of DNA without the subject’s full, informed consent can only be justified in limited circumstances, for example to solve a serious crime. A collection of samples from individuals where no such consent has been given, or where it has been obtained by extortion, has been ruled illegal by many international bodies, and the very existence of such a database is dangerous.

ESHG calls on responsible authorities worldwide to ensure that human DNA is collected only from individuals suspected of having committed serious crimes. Obtaining and documenting informed consent is an essential cornerstone of the proper research, clinical, and/or diagnostic use of DNA samples.  We are of the opinion that existing databases that do not abide to established legal and ethical principles should be destroyed, and that companies should not provide technology to be used for these purposes, until there is clear evidence that human rights are no longer being violated.

SCAM attempt on ESHG members

Beware of recent scam attempts. Criminals are impersonating association executives to trigger money transfers.

ESHG/Eurogentest two-dimensional variant classification system

An ad hoc working group in ESHG (Johan den Dunnen, Helen Firth, Nicole de Leeuw, Hans Scheffer and Gunnar Houge) has proposed a two dimensional system for variant classification, with a molecular and clinical arm. Everybody is free to test the system, and feedback is highly appreciated! The system with information and explanations use <link internal-link internal link in current>can be found here.

Response to ‘Adopt a moratorium on heritable gene editing’

The past year has seen many developments in the field of gene editing, both in somatic and in germ line applications. Editing the germline means that changes will be made in every cell in the body and will be inherited by future generations. While carrying out such editing in a research setting is important for a greater understanding, clinical germline editing leading to a pregnancy carries considerable practical and ethical risks, at least at present.

The announcement of the birth of twins in China, following a procedure of germline gene editing performed by Dr He Jiankui, has attracted the attention of the international media, as well as raising serious concerns in the scientific community, and the Chinese authorities also condemned these procedures as being illegal in the country. A few scientists in the USA were informed about the intentions of Dr He Jiankui both before and during the course of his experiments. However, formal reports to ethics committees or other relevant institutions were never made. 

Now clinical germline gene editing has taken place, and the scientific community worldwide has been shaken and is questioning its responsibilities.

Over the past years, there has been a general consensus that it would be irresponsible to carry out any clinical germline gene editing at the present time, and that there is a need to promote research to build up a robust core of knowledge on the subject, as well as to explore more broadly the views of society on the scope and limits of this research and its potential future application. ESHG has contributed to these discussions and to this general consensus, notably through our Recommendations on Germline Gene Editing released in April 2018, and jointly signed with ESHRE.

Notwithstanding the wide scientific consensus on the inadvisability of clinical germline gene editing, clinical experiments have taken place. For this reason, a group of eminent scientists (Lander et al) has proposed that the scientific community should take a stronger position in the form of a moratorium on clinical, heritable, gene editing.

The moratorium would not prevent human germline gene editing research that will not lead to a pregnancy, neither will it discard the possibility of introducing germline gene editing in the future should nations so wish after adequate and thorough reflection, together with appropriate and sound international dialogue and supervision.

Such a moratorium will mean that every scientist pledges to adhere to a moral code of conduct according to which they will voluntarily refrain from and will not support any use of clinical germline editing - unless certain, clearly-defined conditions are met. These latter would entail a period of public notice of the specific intents, during which there would be robust international discussion about the pros and cons of doing so. Within individual nations there would also be debate to explore whether a broad societal consensus on whether to proceed with clinical human germline editing at all might be reached, as well as on the appropriateness of the proposed application.

The moratorium will also entail potential collaborators, ethics committees and peer-reviewed journals observing a ‘scientific embargo’. Such journals are the gatekeepers of trustworthy scientific communication across the world, and this requirement will involve more stringent ethical review and filtering.

As a scientific society with a commitment to contributing to the responsible translation of advancements in human genetics into a benefit for patients and society as a whole, we believe that it is our responsibility to make an unequivocal statement on this issue in response to the plea of our eminent colleagues, in order to provide clear direction to our members.

The ESHG, while considering fundamental and pre-clinical safety research on human germline editing to be not only justified, but necessary, supports the call for a global moratorium on all clinical uses of human germline editing - in sperm, eggs or embryos - that will lead to a pregnancy and/or to the creation of genetically modified children.

We urge relevant institutions to consider this plea for a moratorium in all their pertinent rulings, and to provide appropriate information to society as a whole so that adequately informed discussion may take place.

ESHG's statement to China’s mass collection of human DNA without informed consent

China’s mass collection of human DNA without informed consent offends against international regulations.

ESHG joins ASHG in Denouncing Attempts to Link Genetics and the Concept of Racial Supremacy

The ESHG joins the American Society of Human Genetics in denouncing the misuse of genetics in support of racial theories. Not only is this dangerous and immoral, but it also has no base in science. Although it is possible to claim that a person belongs to a particular race based on their appearance, race cannot be identified by genetics.

Our members are dedicated to improving human health and well-being, for all, and we condemn very strongly any attempt to use our work to the benefit of any particular section of society, or to propagate hate and extremism.

Discover the ESHG YouTube Channel

See the videos of selected Educational Sessions, Plenaries and Symposia.

Better understanding and stricter controls are needed on the use of ancestry databases

In recent months, there have been reports in the media concerning the use for law enforcement purposes of personal genetic information submitted to commercial companies in the interests of determining ancestry. This has raised questions that need wider scrutiny and debate.

Such ancestry databases collect and store genetic information provided by paying customers who, in exchange, obtain access to a database where they may be able to find genetic matches with other customers, and so establish a degree of relatedness. Companies usually state that consumers’ genetic information will be kept private and confidential within the context of the ancestry database and will not be shared with third parties without their consent, with the exception of their being compelled to do so by law enforcement authorities.

A clear definition of the categories or limits of such cases is not provided by the companies, since this would be variable depending on the circumstance, as well as from country to country. However, this unavoidable imprecision may leave room for misinterpretation and an incomplete understanding of the facts from the customer’s perspective.

The legal framework under which any one company selling ancestry testing and holding the database operates is another potential problem. It would be plausible to assume this would be according to the regulations of the country where the company is registered, which might in itself not be familiar to the customer. However, it would be reasonable to speculate that there might also be a complex interplay with the legal framework of the country of origin of the customer, as well as of international regulation, particularly when serious crimes or immigration policies are involved.

Furthermore, the customer might reasonably assume that such particular circumstances would apply in the case where they themselves are suspected of committing a crime. Instead, those cases reported recently show that access to these databases has been exploited by authorities for the purpose of looking for relatives or fellow nationals of a suspect, who is not himself a customer of the company, with the aim of confirming identity or nationality. In order to do this, every search has to examine data from a large group of customers and not only one individual or a small, restricted group. This represents a serious threat to the privacy of individuals not suspected of committing a crime.

This is not an ‘in principle’ matter. Instances of non-paternity, for example, could be revealed through this process. If others were to gain access to the database, this information could be exploited for personal or even criminal reasons.

Informed consent of the person involved is waived in cases of law enforcement, but such consent is still needed for the initial request for testing and registration to the database. Understanding this level of complexity is not trivial and can test the implication of ‘meaningful’ alongside ‘informed consent’.

Finally, the use of commercial databases containing data acquired mainly for ‘recreational’ use, might not be fully compliant with the recently published guidelines for the storage and use of genetic data (Forensic Genetics Policy Initiative’s 2017 Report: ‘Establishing best practice for forensic DNA databases’) from a technical and procedural perspective.

On this basis, we would encourage all relevant stakeholders to start discussions on the use for forensic purposes of genetic information available in the public domain and in non-forensic databases. Access to a private genetic information outside of the scope of the individual consent is an exception that responds to a specific goal: to contribute to justice. This access must be established through laws or the constitution, so as to guarantee the protection of innocent people.

We urge current and future customers to acquire all the information needed before undertaking commercial genetic testing, particularly for purposes that are not health-related.

ESHG welcomes the Council of Europe’s new protocol on genetic testing

The Council of Europe’s protocol on genetic testing for health purposes* came into force yesterday (Sunday 1 July). The protocol, an addition to the Convention on Human Rights and Biomedicine, lays down rules on the conduct of genetic tests, including direct-to-consumer testing. It specifies the conditions under which tests may be carried out on persons not able to consent, with particular attention to children, and addresses privacy issues and the right to information obtained through genetic testing. It also covers counselling and screening.

The protocol enters into force thanks to its ratification by five Council of Europe member states (Norway, Montenegro, the Republic of Moldova, Slovenia and Portugal). It has also been signed by five others – the Czech Republic, Finland, France, Iceland and Luxembourg. The major push for ratification came from the Czech Presidency of the Council of Europe, following extensive lobbying by the Czech Society of Medical Genetics and Genomics.  “It was a major effort on our part,” says Professor Milan Macek, President of the Czech Society, “and we are delighted by the result.”

“At a time when genetics and genomics are advancing so rapidly, issues surrounding genetic testing take on an even greater importance than before,” says ESHG President Professor Gunnar Houge, University of Bergen, Norway. “New technologies and discoveries provide huge potential for the improvement of human health, but alongside that can go the potential for misuse. The ESHG therefore welcomes the Council of Europe protocol and believes that it will be an important factor in ensuring that genetic progress continues to be applied in the most ethical way possible to the benefit of all concerned.”

*<link https: www.ncbi.nlm.nih.gov pmc articles pmc2986683 pdf ejhg200984a.pdf> www.ncbi.nlm.nih.gov/pmc/articles/PMC2986683/pdf/ejhg200984a.pdf ).

ESHG 2018 Conference Press Releases available

The press releases of the European Human Genetics Conference 2018 in Milan are now available.

Tuuli Lappalainen wins the 2018 Leena Peltonen Prize

The winner of this year’s Leena Peltonen prize is Tuuli Lappalainen. The prize is to be awarded at the ESHG annual meeting in Milan.

Welcome to the new ESHG website

The ESHG website has been re-designed.

Suggest a speaker for an upcoming ESHG Conference

Let us know if you heard a great talk from an excellent speaker you would wish to see at one the the next ESHG meetings.

In Memory of John Sulston

A personal statement from Christine Patch, President of the ESHG.

ESHRE-ESHG joint paper on recent developments in genetics & medical assisted reproduction

Two leading European professional societies, the European Society of Human Genetics and the European Society for Human Reproduction and Embryology, have worked together since 2004 to evaluate the impact of fast research advances at the interface of assisted reproduction and genetics, including their application into clinical practice.

Council of Europe adopted recommendations on germline gene editing

"The use of new genetic technologies in human beings"

ESHG welcomes Kuwait’s repeal of the DNA law

The repeal of the law mandating the collection of DNA from all Kuwaiti residents and visitors to the country is good for individuals concerned about their privacy and human rights, and for medical and scientific research in Kuwait and worldwide.

"Gen-Equip" project wins European Health Award 2017

The ESHG wishes to congratulate the "Gen-Equip Project" and ESHG Members Heather Skirton and Leigh Jackson for winning the European Health Award 2017 at the European Health Forum Gastein!

The European Society of Human Genetics condemns move to impose obligatory genetic testing for employees in the USA

A Bill that would allow companies to require employees to undergo genetic testing and disclose the results to their employers, or risk having to make health insurance payments of thousands of dollars extra, was recently approved by the US House of Representatives Committee on Education and the Workforce. The European Society of Human Genetics (ESHG) defends the principle that employees should be employed on the basis of their skills and expertise, and not on their future health risks.

• 2024 Press Releases
• 2023 Press Releases
• 2022 Press Releases
• 2021 Press Releases
• 2020 Press Releases
• 2019 Press releases
• Media & Online Policy
• Media Contact
• Proposed EU Regulation on Medical Devices
• ESHG Newsletter Archive
• Genetic Sounds - The ESHG Podcast Series
• New variant classification system
• Consultations

Winners 2021

Thirteenth Annual European DNA Day Essay Contest for High School Students

The Winners have been selected!

The European Society of Human Genetics is delighted that students from  22 countries submitted 194 essays and 13 videos this year.  The evaluation was made involving 53 experts in the field, who selected the following  3 winners and 11 honourable mentions for essay submissions as well as 3 winners and 2 honourable mentions for video subbmissions .

The names of the winners will be announced in front of approximately 5.000 international scientists and doctors attending the European Human Genetics Conference on August 31, 2021.

Winners as well as honourable mentions will receive a  diploma  within the next weeks.  Acknowledgements  will be sent to all submitters.

Winning Submissions

Congratulations to the winners of the 2021 dna day essay contest.

Congratulations to the Winners of the 2021 Video Contest

Honourable Mentions Essays (in alphabetical order)

Honourable Mentions Videos (in alphabetical order)

First Place Winner: EUR 300.- In addition, sponsoring teachers of first place students will receive EUR 1.000.- to organise a science project or to purchase classroom equipment.

Second Place Winner: EUR 200.- In addition, sponsoring teachers of first place students will receive EUR 800.- to organise a science project or to purchase classroom equipment

Special Commendation by the Jury: EUR 100.- In addition, sponsoring teachers of first place students will receive EUR 500.- to organise a science project or to purchase classroom equipment

All participants will receive a certificate of appreciation for their participation in the contest.

Question 2021

‘We can now sequence the genome of all life forms, from viruses to humans. What could be the point of this?’

Write an essay /or shoot a video that starts with “I propose to sequence the genome of … because …”. Think about the benefits and consequences for science and society.

© Copyright 2012 - 2024 | Avada Theme by ThemeFusion | All Rights Reserved | Powered by WordPress